Literature DB >> 9709381

Antibacterial system generated by lactoferrin in mice in vivo is primarily a killing system.

T Zagulski1, P Lipiński, A Zagulska, Z Jarzabek.   

Abstract

A single dose of bovine lactoferrin (BLF) was given intravenously (i.v.) to CFW mice 24 hours (h) prior to the i.v. injection of the E. coli lethal dose (LD100). BLF strongly accelerated the clearance rate of E. coli from the blood as well as its killing rate in the liver, lungs, spleen and kidney. The highest clearing and killing rate was found 5 h after E. coli LD100 injection. The most intensive killing in the organs examined was found in the lungs and kidney. Analysis of organs of i.v. BLF-stimulated mice which survived up to day 30 after the infection by E. coli showed that not all animals were definitely pathogen-free. It was concluded that the defense system generated by BLF in mice in vivo is primarily a bacteria-killing one. The participation and cooperation of reticulo-endothelial (RE)-macrophages and granulocytes in the phagocytosis and killing of E. coli may thus be related to the protective activity of LF.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9709381      PMCID: PMC3230837          DOI: 10.1046/j.1365-2613.1998.00058.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  7 in total

1.  Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice.

Authors:  L A Håversen; I Engberg; L Baltzer; G Dolphin; L A Hanson; I Mattsby-Baltzer
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 2.  Lactoferrin as a natural immune modulator.

Authors:  Jeffrey K Actor; Shen-An Hwang; Marian L Kruzel
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

3.  Influence of bovine lactoferrin on expression of presentation molecules on BCG-infected bone marrow derived macrophages.

Authors:  Shen-An Hwang; Marian L Kruzel; Jeffrey K Actor
Journal:  Biochimie       Date:  2008-04-27       Impact factor: 4.079

Review 4.  Mini-review: Lactoferrin: a bioinspired, anti-biofilm therapeutic.

Authors:  M C Ammons; V Copié
Journal:  Biofouling       Date:  2013       Impact factor: 3.209

5.  Protective effects of human lactoferrin during Aggregatibacter actinomycetemcomitans-induced bacteremia in lactoferrin-deficient mice.

Authors:  S K Velusamy; R Poojary; R Ardeshna; Waad Alabdulmohsen; D H Fine; K Velliyagounder
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

6.  Analysis of Antimicrobial and Antibiofilm Activity of Human Milk Lactoferrin Compared to Bovine Lactoferrin against Multidrug Resistant and Susceptible Acinetobacter baumannii Clinical Isolates.

Authors:  Tyra M Avery; RaNashia L Boone; Jacky Lu; Sabrina K Spicer; Miriam A Guevara; Rebecca E Moore; Schuyler A Chambers; Shannon D Manning; Leon Dent; Dana Marshall; Steven M Damo; Steven D Townsend; Jennifer A Gaddy
Journal:  ACS Infect Dis       Date:  2021-06-09       Impact factor: 5.084

Review 7.  Lactoferrin: Balancing Ups and Downs of Inflammation Due to Microbial Infections.

Authors:  Maria Elisa Drago-Serrano; Rafael Campos-Rodríguez; Julio César Carrero; Mireya de la Garza
Journal:  Int J Mol Sci       Date:  2017-03-01       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.